- 7
- 0
- 约2.84千字
- 约 13页
- 2018-04-17 发布于江西
- 举报
Practitioners of clinical trials have an obligation to take 临床试验人员有义务采取.ppt
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program Director, General Oncology M. D. Anderson CCOP Research Base Practitioners of clinical trials have an obligation to take appropriate steps to protect both the integrity of science and human subjects who participate in research studies Why must we have audits let alone talk about audits? NCI Clinical Trials Quality Assurance Monitoring As the world’s largest sponsor of clinical trials of investigational antineoplastic agents and cancer clinical trials, the NCI must ensure that research data generated under its sponsorship are of high quality, reliable and verifiable. NCI Auditing Division of Cancer Treatment and Diagnosis (DCTD) Cancer Therapy Evaluation Program (CTEP) Clinical Trials Monitoring Branch (CTMB) Purpose of Auditing Document the accuracy of data submitted to the Cooperative Groups/Research Bases Verify investigator compliance with protocol and regulatory requirements Provide and opportunity for the audit team to share information with the institution staff concerning data quality, data management and all aspects of quality assurance Audit Scheduling Main member institutions will be audited within eighteen months after entry of the first patient. For rapid accrual, the initial on-site audit should be done sooner than 18 months. All institutions (main members, affiliates, CCOPs and components) are eligible for an audit every 36 months but may be selected for audit at any time. Components of Auditing Review of IRB Documentation and Informed Consent Content Review of Accountability of Investigational Agents and Pharmacy Operations Review of Patient Case Records Selection of Protocols Cases A minimum of three protocols representing studies conducted should be selected Emphasis to the following types of studies: IND, multi-modality, intergroup, designated prevention trials, those with high accrual
您可能关注的文档
- 2012年《随堂优化训练》英语 新课标北师大版 必修5 Unit 15 warm-up & Lesson 1.ppt
- 晏家街道教师教育工作培训会.ppt
- bondintro_presppt:bondintro_pres.ppt
- 制图——课题5 机件的常用表达方法.ppt
- (苏教版生物)2012届高三一轮《创新设计》课件《性别决定和伴性遗传》.ppt
- 国际海关审价热点问题简介.ppt
- 物理:3.3《平抛运动》课件2(鲁科版必修2).ppt
- 历史课件:《古代希腊民主政治》.ppt
- ConfidenceIntervalsppt:confidenceintervals.ppt
- CoursCombustionAhtmlppt:courscombustionahtml.ppt
最近下载
- 2024年湖南汽车工程职业学院单招职业技能测试题库及答案(历年真题).docx VIP
- 广东省潮州市2024-2025学年高三上学期期末教学质量检测物理试卷.docx VIP
- 上海电力学院大一机械制图C习题本解答(造福学弟,不谢)-新版.pptx
- 广东省潮州市2024-2025学年高二上学期期末教学质量检测物理试卷(含答案).docx VIP
- 新生儿身份识别制度.pptx
- 康迪泰克空气弹簧.pdf VIP
- LY/T 2817-2017山桐子栽培技术规程.pdf
- 缓刑担保承诺书范文.docx VIP
- 记账实操-电梯保养公司会计账务处理分录.doc
- 脑机接口专利关键技术白皮书-复旦大学-2025.pdf VIP
原创力文档

文档评论(0)